Pharma Biotech Financial Model incl. Risk-Adjusted DCF and VC Valuation
Financial Model analyzing a Biopharmaceutical Company using a Risk-AdjustedNPV Valuation Methodology.
404Discussadd_shopping_cart
$269.00
by Profit Vision